Session

PP 05 IBD (Posters)

THE ROAD TO AND SEQUENCE OF BIOLOGICAL THERAPY IN A POPULATION-BASED, EUROPEAN INCEPTION COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE -AN EPI-IBD COHORT STUDY
THE ROAD TO AND SEQUENCE OF BIOLOGICAL THERAPY IN A POPULATION-BASED, EUROPEAN INCEPTION COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE -AN EPI-IBD COHORT STUDY

PP 05 IBD (Posters)  et al.

PROACTIVE THERAPEUTIC DRUG MONITORING FOR INFLIXIMAB MAY REDUCE STEROID EXPOSURE IN IBD
PROACTIVE THERAPEUTIC DRUG MONITORING FOR INFLIXIMAB MAY REDUCE STEROID EXPOSURE IN IBD

PP 05 IBD (Posters)  et al.

TISSUE MICRO-RNAS AS MARKERS OF EARLY DIAGNOSIS AND MONITORING OF COLORECTAL CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
TISSUE MICRO-RNAS AS MARKERS OF EARLY DIAGNOSIS AND MONITORING OF COLORECTAL CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

PP 05 IBD (Posters)  et al.

RISK FOR BACTERIAL INFECTIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH BIOLOGICAL AGENTS
RISK FOR BACTERIAL INFECTIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH BIOLOGICAL AGENTS

PP 05 IBD (Posters)  et al.

VOLUMETRIC MEASUREMENT OF CROHN’S DISEASE ON MAGNETIC RESONANCE ENTEROGRAPHY: FEASIBILITY, CLINICAL UTILITY, AND ROLE IN ASSESSING TREATMENT RESPONSE
VOLUMETRIC MEASUREMENT OF CROHN’S DISEASE ON MAGNETIC RESONANCE ENTEROGRAPHY: FEASIBILITY, CLINICAL UTILITY, AND ROLE IN ASSESSING TREATMENT RESPONSE

PP 05 IBD (Posters)  et al.

COMPARATIVE MULTI-OMICS ANALYSIS IN PERIPHERAL BLOOD IDENTIFIES UNIQUE AND SHARED CORE MOLECULAR SIGNATURES IN IBD, PSORIASIS, RHEUMATOID ARTHRITIS AND SLE
COMPARATIVE MULTI-OMICS ANALYSIS IN PERIPHERAL BLOOD IDENTIFIES UNIQUE AND SHARED CORE MOLECULAR SIGNATURES IN IBD, PSORIASIS, RHEUMATOID ARTHRITIS AND SLE

PP 05 IBD (Posters)  et al.

PROTON PUMP INHIBITORS ARE ASSOCIATED WITH A DISABLING COURSE OF CROHN’S DISEASE
PROTON PUMP INHIBITORS ARE ASSOCIATED WITH A DISABLING COURSE OF CROHN’S DISEASE

PP 05 IBD (Posters)  et al.

PERIODONTITIS IS ASSOCIATED WITH INCREASED DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
PERIODONTITIS IS ASSOCIATED WITH INCREASED DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

PP 05 IBD (Posters)  et al.

EFFECTIVENESS AND SAFETY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB FORMULATION IN INFLAMMATORY BOWEL DISEASE PATIENTS IN CLINICAL REMISSION: A SINGLE CENTRE REAL WORLD EXPERIENCE
EFFECTIVENESS AND SAFETY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB FORMULATION IN INFLAMMATORY BOWEL DISEASE PATIENTS IN CLINICAL REMISSION: A SINGLE CENTRE REAL WORLD EXPERIENCE

PP 05 IBD (Posters)  et al.

SIMPLE SCORING QUESTIONNAIRE FOR ASSESSMENT OF DISEASE SEVERITY AND QUALITY OF LIFE
SIMPLE SCORING QUESTIONNAIRE FOR ASSESSMENT OF DISEASE SEVERITY AND QUALITY OF LIFE

PP 05 IBD (Posters)  et al.

IMPACT OF BODY MASS INDEX ON CLINICAL OUTCOMES IN INTESTINAL BEHÇET’S DISEASE
IMPACT OF BODY MASS INDEX ON CLINICAL OUTCOMES IN INTESTINAL BEHÇET’S DISEASE

PP 05 IBD (Posters)  et al.

THROMBOEMBOLIC EVENTS IN CROHN'S DISEASE: AN EXTRA-DIGESTIVE COMPLICATION TO BE FEARED
THROMBOEMBOLIC EVENTS IN CROHN'S DISEASE: AN EXTRA-DIGESTIVE COMPLICATION TO BE FEARED

PP 05 IBD (Posters)  et al.

EPIDEMIOLOGICAL PROFILE AND MANAGEMENT OF SPECIFIC ANAL FISTULAS
EPIDEMIOLOGICAL PROFILE AND MANAGEMENT OF SPECIFIC ANAL FISTULAS

PP 05 IBD (Posters)  et al.

A NEW ROS-RESISTANT BIFIDOBACTERIUM LONGUM STRAIN PROTECTS AGAINST MURINE COLITIS BY ENHANCING INTESTINAL COLONIZATION
A NEW ROS-RESISTANT BIFIDOBACTERIUM LONGUM STRAIN PROTECTS AGAINST MURINE COLITIS BY ENHANCING INTESTINAL COLONIZATION

PP 05 IBD (Posters)  et al.

IS USTEKINUMAB EFFECTIVE IN CROHN'S DISEASE PATIENTS WITH PARADOXICAL SKIN REACTIONS CAUSED BY TUMOR NECROSIS FACTOR-ALPHA INHIBITORS?
IS USTEKINUMAB EFFECTIVE IN CROHN'S DISEASE PATIENTS WITH PARADOXICAL SKIN REACTIONS CAUSED BY TUMOR NECROSIS FACTOR-ALPHA INHIBITORS?

PP 05 IBD (Posters)  et al.

HUMAN DENTAL-PULP MESENCHYMAL STEM CELLS AMELIORATE TNBS-INDUCED INTESTINAL FIBROSIS VIA BALANCING PRO-AND ANTI-FIBROTIC SIGNALING PATHWAYS
HUMAN DENTAL-PULP MESENCHYMAL STEM CELLS AMELIORATE TNBS-INDUCED INTESTINAL FIBROSIS VIA BALANCING PRO-AND ANTI-FIBROTIC SIGNALING PATHWAYS

PP 05 IBD (Posters)  et al.

EFFECTS OF THE MONASH POUCH DIET ON VOLATILE ORGANIC COMPOUNDS (VOC) IN THE POUCH LUMEN IN PATIENTS WITH AN ILEOANAL POUCH
EFFECTS OF THE MONASH POUCH DIET ON VOLATILE ORGANIC COMPOUNDS (VOC) IN THE POUCH LUMEN IN PATIENTS WITH AN ILEOANAL POUCH

PP 05 IBD (Posters)  et al.

THE ROLE OF REGULATION OF ENDOCANNABINOID SYSTEM ACTIVITY IN INHIBITION OF INTESTINAL FIBROSIS IN IBD
THE ROLE OF REGULATION OF ENDOCANNABINOID SYSTEM ACTIVITY IN INHIBITION OF INTESTINAL FIBROSIS IN IBD

PP 05 IBD (Posters)  et al.

EFFICACY OF UPADACITINIB FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE BY DISEASE DURATION: A POST HOC ANALYSIS OF PHASE 3 INDUCTION AND MAINTENANCE STUDIES
EFFICACY OF UPADACITINIB FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE BY DISEASE DURATION: A POST HOC ANALYSIS OF PHASE 3 INDUCTION AND MAINTENANCE STUDIES

PP 05 IBD (Posters)  et al.

A SPECIFIC MICROBIOTA SIGNATURE IS ASSOCIATED TO IMMUNOTHERAPY-RELATED COLITIS AS ASSESSED BY A MACHINE LEARNING APPROACH – A COMPARATIVE STUDY WITH INFLAMMATORY BOWEL DISEASES AND HEALTHY CONTROLS
A SPECIFIC MICROBIOTA SIGNATURE IS ASSOCIATED TO IMMUNOTHERAPY-RELATED COLITIS AS ASSESSED BY A MACHINE LEARNING APPROACH – A COMPARATIVE STUDY WITH INFLAMMATORY BOWEL DISEASES AND HEALTHY CONTROLS

PP 05 IBD (Posters)  et al.

Item 1 - 20 / 826
1
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42